Acquired immunodeficiency syndrome-associated lymphomas are efficiently lysed through complement-dependent cytotoxicity and antibody-dependent cellular cytotoxicity by rituximab (Q61906677)
Jump to navigation
Jump to search
scientific article published in December 2002
Language | Label | Description | Also known as |
---|---|---|---|
English | Acquired immunodeficiency syndrome-associated lymphomas are efficiently lysed through complement-dependent cytotoxicity and antibody-dependent cellular cytotoxicity by rituximab |
scientific article published in December 2002 |
Statements
Acquired immunodeficiency syndrome-associated lymphomas are efficiently lysed through complement-dependent cytotoxicity and antibody-dependent cellular cytotoxicity by rituximab (English)
Rosanna Gramigna
Valeria Facchinetti
Gianluca Gaidano
1 December 2002
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference